Table 3 Third stage protein substitute transition history of children with PKU
Patient No | Gender | Type of second stage protein substitute | Type of third stage protein substitute | The age third stage protein substitute transition commenced (years) | The age third stage protein substitute transition finished (years) | Duration (months) |
|---|---|---|---|---|---|---|
1 | F | Semi-solid | Liquid | 3.5 | 3.7 | 2 |
2 | M | Semi-solid | Liquid | 3.1 | 3.5 | 5 |
3 | F | Semi-solid | Liquid | 5.5 | 6.5 | 12 |
4 | M | Semi-solid | Liquid | 3.8 | 4.3 | 6 |
5 | M | Semi-solid | Powder + Liquid†| 5.2 | 6.6 | 17 |
6 | M | Semi-solid | Liquid | 5.3 | 5.3 | 0 |
7 | F | Semi-solid | Powder | 5.4 | 6.7 | 16 |
8 | M | Semi-solid | Liquid | 3.9 | 4.0 | 1 |
9 | F | Semi-solid | Liquid | 5.0 | 5.6 | 7 |
10 | M | Semi-solid | Liquid | 4.2 | 4.4 | 2 |
11 | F | Semi-solid | Liquid | 3.3 | 4.7 | 17 |
12 | F | Semi-solid | Liquid | 8.0 | 8.0 | 0 |
13 | F | Semi-solid | Liquid | 4.7 | 4.7 | 0 |
14 | M | Semi-solid | Liquid | 4.9 | 5.3 | 5 |
15 | M | Semi-solid | Powder + Liquid‡ | 4.3 | 6.9 | 32 |
16 | F | Semi-solid | Liquid | 5.3 | 5.6 | 4 |